Global Cancer Epidemic: Impact, Challenges and Future Trends Thomas Gross, MD, PhD Deputy Director...
-
Upload
gabriella-fields -
Category
Documents
-
view
215 -
download
1
Transcript of Global Cancer Epidemic: Impact, Challenges and Future Trends Thomas Gross, MD, PhD Deputy Director...
Global Cancer Epidemic: Impact, Challenges and Future Trends
Thomas Gross, MD, PhDDeputy Director of Science
Center for Global HealthNational Cancer Institute
Bethesda, MD 20892Email: [email protected]
Summary of Presentation
• Cancer rates, cancer types & cancer mortality vary widely around the world
• Eight environmental or lifestyle risk factors that account for ~50% of all cancer deaths• Tobacco exposure is by far the most prominent• Strategies to reduce these risk factors will have a
tremendous impact on reducing the burden of cancer globally
• Socioeconomic factors affect cancer rates and mortality and will become a bigger challenge in the future
Fast Facts About Cancer
• Cancer is a global epidemic and a leading cause of death worldwide, accounting for 7.6 million deaths or around 13% of all deaths in 2008.
• Worldwide, cancer now causes more deaths than HIV/AIDS, tuberculosis, and malaria combined.
• More than 70% of all cancer deaths occur in low- and middle-income countries.
CANCER RATES, TYPE AND MORTALITY VARIES WORLDWIDE
Data Source: Jemal, A. et al., CA CANCER J CLIN 2011;61:69–90
The Worldwide Burden of Cancer in Men(Top 10 Cancer Sites)
Total: 6,629,100 Total: 4,225,700
Most Common Cancer Site in Males
Source: GLOBOCAN 2008 via the American Cancer Society
Data Source: Jemal, A. et al., CA CANCER J CLIN 2011;61:69–90
The Worldwide Burden of Cancer in Women(Top 10 Cancer Sites)
Total: 4,225,700 Total: 3,345,800
Most Common Cancer Site in Females
Source: GLOBOCAN 2008 via the American Cancer Society
CAUSES OF CANCERVARY WORLDWIDE
Male Stomach Cancer ASRs from Population-based Registries:
Data Source: Curado. M. P., Edwards, B., Shin. H.R., Storm. H., Ferlay. J., Heanue. M. and Boyle. P., eds (2007) Cancer Incidence in Five Continents, Vol. IX IARC Scientific Publications No. 160, Lyon, IARC. http://www-dep.iarc.fr/
Genetic Pre-disposition vs Environment Exposure
Eight Risk Factors Account for 50% of Deaths from Cancer
Risk Factors Vary In Their Contribution To Cancers In Different Settings
Percentage of Cancers
Attributable to Risk Factor
Source: The Cancer Atlas
Diseases Associated with Tobacco Exposure
LungOralBladderLarynxEsophagusPancreasColorectal StomachLeukemiaCervix
Sudden infant deathFetal death, stillbirthReduced fertilityLow birth weightPregnancy complicationsLung function in infants
Cardiovascular DiseasesRespiratory DiseasesAsthma control
Low bone densityErectile Dysfunction Peptic ulcer diseaseDental diseases
The Health Consequences of Smoking: A Report of the Surgeon General , 2004
Cancers Other Medical Conditions
Infections cause about:
•18% of cancers globally(>2 million cases/year)
•26% of cancers in LMICs
•40% of cancers in Africa
(from Worldmapper, www.worldmapper.org
Territories are sized in proportion to the absolute number of
people who died from liver cancer
annually
Liver Cancer Kills 1% of the World’s Population
Cancer of the liver cause ~1% of all deaths worldwide (~100 deaths per million people per year) and 9% of all deaths from cancer.
S. Korea
China
Taiwan Japan
India
10
IMPACT OF SOCIOECONOMIC STATUS ON CANCER BURDEN
Data Source: Globocan 2008
Overall (non-adjusted) Cancer Incidence Rates (Per 100K, Both Genders; All Cancers Except Non-Melanoma Skin)
An
nu
al C
an
cer
Cas
es (
Mil
lio
ns)
5.7 7.4
7.5
12.9
0
5
10
15
20
25
2010 2030
Less DevelopedMore Developed
57%
64%
Trends in Cancer IncidenceDeveloped vs. Less Developed Countries
Data derived from GLOBOCAN 2008
Data from SEER 2010
Cancer incidence with age in USA
Cancer in 0-14 yr olds as % of all cancer
Globocan 2002
% o
f A
ll C
ance
rs
• Incidence per capita of pediatric cancer is similar around the world
Trends in Cancer Mortality Developed vs. Less Developed Countries
Cancer mortality in more developed countries projected decrease by <30% by 2030
Cancer mortality in less developed countries projected to increase by >70% by 2030
By 2030 - 85% of all cancer deaths may be occurring in low-middle income countries
The increase In cancer mortality in LMIC is largely due to: Delay in accurate diagnoses Lack of unawareness about cancer and potential value of therapy Lack of access and ability to deliver potentially curative therapy Abandonment of therapy
Data Source: Globocan 2008
Female Breast Cancer Incidence(Per 100,000)
Total Expenditure on Health (for 2011 in US$)
Breast Cancer and Socioeconomic Status
RISK FACTORS FOR BREAST CANCER IN DEVELOPED COUNTRIES
• Higher maternal age at first birth• Reduced parity
– Each live birth results in a decrease of 7% in relative risk of breast cancer (Lancet 2002;360:187-195)
• Reduced breast feeding– For every 12 months of breast
feeding results in a decrease of 4% in relative risk of breast cancer (Lancet 2002;360:187-195)
• Obesity & “lifestyle” factors
Incidence of Breast Cancer & Outcomes Correlate with GDP
Source: Harford JB, Lancet Oncol. 2011 Mar;12(3):306-12.
Institute of Medicine (IOM REPORT)High-income countries should:•Resist the temptation to focus on exporting the latest, most expensive technologies that may be appropriate for wealthy countries…•Partner with countries to develop resource-appropriate strategies focused on decreasing the burden and mortality due to cancer.
IOM Report
Some low- or middle income countries (including physicians & governments) have a related temptation to WANT the latest, most expensive technologies as opposed to more resource-appropriate “alternatives” which may be seen as 2nd rate solutions.
A National Cancer Control Program in Context
Broader Social Context
Healthcare System
National Cancer Control Program
PrimaryPrevention
EarlyDetection
PalliativeCare
CurativeTreatment
Survivorship
This is for title
• This is for text
NCI - CGH Global Footprint
Acknowledgments
• Ted Trimble, MD, MPH – Director of NCI-CGH• Lisa Stevens, PhD – Deputy Director of NCI-CGH• Joe Harford, PhD - Senior Advisor NCI-CGH• Ann Chao, PhD – East Asia Representative, NCI-CGH